Bhawna Sirohi, M.B.B.S., D.C.H, M.R.C.P. profile in India Cancer Research Database

INCREDB ID : 241

Home >> Investigator Page

Previous Next

Bhawna Sirohi, M.B.B.S., D.C.H, M.R.C.P.
Head of Department

Artemis Health Institute

Medical and Haemato Oncology

Sector - 51

Gurgaon - 122 001

Haryana

E-mail: bhawnas@artemishealthsciences.com

URL: http://www.artemishospital.in/profile.php?folder_name=bhawnasirohi

Positions Held:

Position	Affiliation	Time Period
Head of Department	Artemis Health Institute, Gurgaon, India	2010-Present
Director	Max Healthcare, New Delhi, India	2009
Consultant	Royal Marsden Hospital, London, UK

Area of Specialization:

Medical Oncology

Publications:

1.	Sirohi B. Cancer management in the twenty-first century in India. Indian Journal of Medical and Paediatric Oncology. 2010. 31, 49-50. [PubMed]
2.	Sirohi B. New Delhi metallo-beta-lactamase 1. The Lancet Infectious Diseases. 2010. 10, 750; author reply 752-752. [PubMed]
3.	Cook, N., Basu, B., Biswas, S., Kareclas, P., Mann, C., Palmer, C., Thomas, A., Nicholson, S., Morgan, B., Lomas, D., Sirohi, B., Mander, A. P., Middleton, M. and Corrie, P. G. A phase 2 study of vatalanib in metastatic melanoma patients. European Journal of Cancer. 2010. 46, 2671-2673. [PubMed]
4.	Powles, R., Sirohi, B. and Niederwieser, D. The role of the European haematologist in a large irradiation emergency: the European Blood and Marrow Transplantation Society (EBMT) Nuclear Accident Committee (NAC). Health Physics. 2010. 98, 810-814. [PubMed]
5.	Basu, B., Sirohi, B. and Corrie, P. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin. Endocrine-related Cancer. 2010. 17, R75-90. [PubMed]
6.	Basu, B., Biswas, S., Wrigley, J., Sirohi, B. and Corrie, P. Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies. Expert Review of Anticancer Therapy. 2009. 9, 1583-1598. [PubMed]
7.	Sirohi, B. and Powles, R. Lenalidomide in multiple myeloma. Expert Review of Anticancer Therapy. 2009. 9, 1559-1570. [PubMed]
8.	Sirohi, B., Leary, A. and Johnston, S. R. Ipsilateral breast tumor recurrence: is there any evidence for benefit of further systemic therapy? The Breast Journal. 2009. 15, 268-278. [PubMed]
9.	Fliedner, T. M., Chao, N. J., Bader, J. L., Boettger, A., Case, C., Chute, J., Confer, D. L., Ganser, A., Gorin, N. C., Gourmelon, P., Graessle, D. H., Krawisz, R., Meineke, V., Niederwieser, D., Port, M., Powles, R., Sirohi, B., Weinstock, D. M., Wiley, A. and Coleman, C. N. Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop. Stem Cells. 2009. 27, 1205-1211. [PubMed]
10.	Sirohi, B., Powles, R., Singhal, S., Smith, K., Jones, R. L., Saso, R., Kulkarni, S., Treleaven, J., Swansbury, G. J., Potter, M., Morgan, G. and Mehta, J. Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype. Leukemia & Lymphoma. 2008. 49, 2284-2290. [PubMed]
11.	Sirohi, B. and Smith, K. Bevacizumab in the treatment of breast cancer. Expert Review of Anticancer Therapy. 2008. 8, 1559-1568. [PubMed]
12.	Fliedner, T. M., Powles, R., Sirohi, B. and Niederwieser, D. Radiologic and nuclear events: the METREPOL severity of effect grading system. Blood. 2008. 111, 5757-5765. [PubMed]
13.	Leary, A. F., Sirohi, B. and Johnston, S. R. Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer. Breast Cancer Research. 2007. 9, 112. [PubMed]
14.	Sirohi, B., Ashley, S., Norton, A., Popat, S., Hughes, S., Papadopoulos, P., Priest, K. and O'Brien, M. Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival. Journal of Thoracic Oncology. 2007. 2, 735-740. [PubMed]
15.	Sirohi, B., Cunningham, D., Norman, A., Last, K., Chau, I., Horwich, A., Oates, J., Chong, G. and Wotherspoon, A. Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL). Hematology. 2007. 12, 149-153. [PubMed]
16.	Sirohi, B., Powles, R., Cavanagh, J., Oakervee, H., Dyer, P., Rintala, T., Kulkarni, S., Rudin, C., Horton, C., Treleaven, J. and Morgan, G. Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy. Hematology. 2007. 12, 113-115. [PubMed]
17.	Murphy, F., Sirohi, B. and Cunningham, D. Stem cell transplantation in Hodgkin lymphoma. Expert Review of Anticancer Therapy. 2007. 7, 297-306. [PubMed]
18.	Arkenau, H. T., Chong, G., Cunningham, D., Watkins, D., Sirohi, B., Chau, I., Wotherspoon, A., Norman, A., Horwich, A. and Matutes, E. Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. Haematologica. 2007. 92, 271-272. [PubMed]
19.	Sirohi, B. and Powles, R. Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. European Journal of Cancer. 2006. 42, 1671-1683. [PubMed]
20.	Bird, J. M., Fuge, R., Sirohi, B., Apperley, J. F., Hunter, A., Snowden, J., Mahendra, P., Milligan, D., Byrne, J., Littlewood, T., Fegan, C., McQuaker, G., Pagliuca, A., Johnson, P., Rahemtulla, A., Morris, C. and Marks, D. I. The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study. British Journal of Haematology. 2006. 134, 385-390. [PubMed]
21.	Sirohi, B., Powles, R., Rudin, C., Singhal, S., Kulkarni, S., Saso, R., Horton, C., Mehta, J. and Treleaven, J. Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft. Hematology. 2005. 10, 361-364. [PubMed]
22.	Prescot, A. P., Dzik-Jurasz, A. S., Leach, M. O., Sirohi, B., Powles, R. and Collins, D. J. Localized COSY and DQF-COSY 1H-MRS sequences for investigating human tibial bone marrow in vivo and initial application to patients with acute leukemia. Journal of Magnetic Resonance Imaging. 2005. 22, 541-548. [PubMed]
23.	Vaidya, S. J., Ortin, M., Lopez-Duarte, M., Sirohi, B., Powles, R., Treleaven, J. and Richard, C. Haemopoietic progenitor cell transplantation in patients with previous history of invasive fungal infection. Leukemia & Lymphoma. 2005. 46, 1143-1150. [PubMed]
24.	Alvares, C. L., Davies, F. E., Horton, C., Patel, G., Powles, R., Sirohi, B., Zuha, R., Gatt, A., Saso, R., Treleaven, J. G., Dearden, C. E., Potter, M. N., Ethell, M. E. and Morgan, G. J. Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments. British Journal of Haematology. 2005. 129, 607-614. [PubMed]
25.	Pearson, I. C., Sirohi, B., Powles, R., Treleaven, J. and Mortimer, P. S. The impact on resources of prevalence and nature of skin problems in a modern intensive haemato-oncology practice. Hematology. 2004. 9, 415-423. [PubMed]
26.	Sirohi, B. and Powles, R. Multiple myeloma. Lancet. 2004. 363, 875-887. [PubMed]
27.	Durie, B. G., Kyle, R. A., Belch, A., Bensinger, W., Blade, J., Boccadoro, M., Child, J. A., Comenzo, R., Djulbegovic, B., Fantl, D., Gahrton, G., Harousseau, J. L., Hungria, V., Joshua, D., Ludwig, H., Mehta, J., Morales, A. R., Morgan, G., Nouel, A., Oken, M., Powles, R., Roodman, D., San, M., Shimizu, K., Singhal, S., Sirohi, B., Sonneveld, P., Tricot, G. and Van, N. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. The Hematology Journal. 2003. 4, 379-398. [PubMed]
28.	Shaw, B. E., Peggs, K., Bird, J. M., Cavenagh, J., Hunter, A., Alejandro, M., Russell, N. H., Sirohi, B., Towlson, K., Williams, C. D. and Marks, D. I. The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. British Journal of Haematology. 2003. 123, 886-895. [PubMed]
29.	Elnenaei, M. O., Gruszka-Westwood, A. M., A'Hernt, R., Matutes, E., Sirohi, B., Powles, R. and Catovsky, D. Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A. Haematologica. 2003. 88, 529-537. [PubMed]
30.	Powles, R., Sirohi, B., Treleaven, J., Kulkarni, S., Tait, D., Singhal, S. and Mehta, J. The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia. Blood. 2002. 100, 1641-1647. [PubMed]

Education
::	M.B.B.S. Lala Lajpat Rai Memorial Medical College, Meerut, India
::	D.C.H Lala Lajpat Rai Memorial Medical College, Meerut, India
::	M.R.C.P.
Member
::	Secretary, EBMT Nuclear Accident Committee
::	American Society of Clinical Oncology
::	American Society of Hematology
::	European School of Medical Oncology
::	Chronic Leukaemia Working Party of EBMT
::	Multiple Myeloma Working sub-Committee of EBMT
::	European Haematology Association
::	British Society for Blood and Marrow Transplantation
::	Association of Cancer Physicians, UK
::	Indian Cooperative Oncology Network
::	Indian Society of Medical and Pediatric Oncology

Type of Neoplasms

Pulmonary system

Lung

Breast

Female

Hemato-lymphoid system

Lymph nodes

Last modified on : Mar 4, 2011

India Cancer Research Database has been developed by the Institute of Bioinformatics with funding from the Department of Biotechnology, Government of India.